Denatonium

DB18588InvestigationalSmall molecule

Denatonium: Overview.

Mechanism: Pharmacologically active on Taste receptor type 2 member 10, Taste receptor type 2 member 4, and Taste receptor type 2 member 14
Curator reviewed
Formula / weight: C₂₁H₂₉N₂O · 325.475 g/mol (avg)
Also known as: Benzenemethanaminium, n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-n,n-diethyl · Benzyldiethyl((2,6-xylylcarbamoyl)methyl)ammonium

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyZFQMTVNLDNXRNQ-UHFFFAOYSA-OSMILESCC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC1=CC=CC=C1

Targets

What you can answer from here — as of September 21, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Denatonium, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.